-
1by Signorovitch, James Zhou, Zhou Ryan, Jason Anhorn, Rachel Chawla, Anita Published in Journal of medical economics (01.02.2019)“...Aims: Broad molecular profiling of patients with advanced non-small cell lung cancer (NSCLC) is strongly advised to optimize genomic matching with available...”
-
3by Kelley, Eli F Snyder, Eric M Alkhatib, Nimer S Snyder, Scott C Sprissler, Ryan Olson, Thomas P Akre, Monica K Abraham, Ivo Published in Journal of medical economics (02.12.2018)“...Aims: Hypertension is the strongest modifiable risk factor for cardiovascular disease, affecting 80 million individuals in the US and responsible for ∼360,000...”
-
4by Ree, Anne Hansen Nygaard, Vigdis Boye, Kjetil Heinrich, Daniel Dueland, Svein Bergheim, Inger Riise Johansen, Christin Beiske, Klaus Negård, Anne Lund-Iversen, Marius Nygaard, Vegard Hovig, Eivind Nakken, Sigve Nasser, Salah Julsrud, Lars Reisse, Claudius H Ruud, Espen A Kristensen, Vessela N Flørenes, Vivi A Geitvik, Gry A Lingjærde, Ole Christian Børresen-Dale, Anne-Lise Russnes, Hege G Mælandsmo, Gunhild M Flatmark, Kjersti Published in Acta oncologica (02.07.2020)“...Background: In precision cancer medicine, the challenge is to prioritize DNA driver events, account for resistance markers, and procure sufficient information...”
-
5by Kosorok, Michael R Laber, Eric B Small, Dylan S Zeng, Donglin Published in Journal of the American Statistical Association (03.03.2021)“...We introduce the Theory and Methods Special Issue on Precision Medicine and Individualized Policy Discovery. The issue consists of four discussion papers,...”
-
6by Schulz, Juliana Moodie, Erica E. M Published in Journal of the American Statistical Association (02.03.2021)“...The goal of precision medicine is to tailor treatment strategies on an individual patient level. Although several estimation techniques have been developed for...”
-
7by Yadlowsky, Steve Pellegrini, Fabio Lionetto, Federica Braune, Stefan Tian, Lu Published in Journal of the American Statistical Association (05.07.2020)“...While sample sizes in randomized clinical trials are large enough to estimate the average treatment effect well, they are often insufficient for estimation of...”
-
8by Huling, Jared D Smith, Maureen A Chen, Guanhua Published in Journal of the American Statistical Association (14.10.2020)“...Health care payments are an important component of health care utilization and are thus a major focus in health services and health policy applications...”
-
9by Cui, Yifan Tchetgen Tchetgen, Eric Published in Journal of the American Statistical Association (10.12.2020)“...There is a fast-growing literature on estimating optimal treatment regimes based on randomized trials or observational studies under a key identifying...”
-
10“...A dynamic treatment regime (DTR) is a sequence of decision rules that adapt to the time-varying states of an individual. Black-box learning methods have shown...”
-
11by Hellings, P. W Fokkens, W. J Bachert, C Akdis, C. A Bieber, T Agache, I Bernal-Sprekelsen, M Canonica, G. W Gevaert, P Joos, G Lund, V Muraro, A Onerci, M Zuberbier, T Pugin, B Seys, S. F Bousquet, J Published in Allergy (Copenhagen) (2017)“...Precision medicine (PM) is increasingly recognized as the way forward for optimizing patient care. Introduced in the field of oncology, it is now considered of...”
-
12by Rodriguez-Rodriguez, Lorna Ganasen, Shridar Hirshfield, Kim M Khiabanian, Hossein Riedlinger, Gregory“...Precision medicine is rapidly becoming the standard-of-care for the treatment of cancer patients. This is made possible, in part, by the ready availability and...”
edited by Rodriguez-Rodriguez, Lorna ¬[Herausgeber]
[2019]
-
13by Ramaswami, Ramya Bayer, Ronald Galea, Sandro Published in Annual review of public health (01.04.2018)“...Over the past decade, precision medicine (PM) approaches have received significant investment to create new therapies, learn more about disease processes, and...”
-
14“...This corrects the article DOI: 10.1038/nbt.4210...”
-
15by Amin, Mahul B Greene, Frederick L Edge, Stephen B Compton, Carolyn C Gershenwald, Jeffrey E Brookland, Robert K Meyer, Laura Gress, Donna M Byrd, David R Winchester, David P Published in CA: a cancer journal for clinicians (01.03.2017)“...The American Joint Committee on Cancer (AJCC) staging manual has become the benchmark for classifying patients with cancer, defining prognosis, and determining...”
-
16“...The complex interactions in biological systems have been shown to affect the response to single-targeted therapies which were initially developed under the...”
-
17by Marcon, Alessandro R Bieber, Mark Caulfield, Timothy Published in Genetics in medicine (01.09.2018)“...This study investigated the portrayal of "personalized" and "precision" medicine (PM) in North American news over the past decade. Content analysis of print...”
-
18by Hampel, H O'Bryant, S. E Durrleman, S Younesi, E Rojkova, K Escott-Price, V Corvol, J-C Broich, K Dubois, B Lista, S Published in Climacteric : the journal of the International Menopause Society (04.03.2017)“...After intense scientific exploration and more than a decade of failed trials, Alzheimer's disease (AD) remains a fatal global epidemic. A traditional research...”
-
19“...After decades of discovery, inherited variations have been identified in approximately 20 genes that affect about 80 medications and are actionable in the...”
-
20by Gao, Wei Emaminejad, Sam Nyein, Hnin Yin Yin Challa, Samyuktha Chen, Kevin Peck, Austin Fahad, Hossain M Ota, Hiroki Shiraki, Hiroshi Kiriya, Daisuke Lien, Der-Hsien Brooks, George A Davis, Ronald W Javey, Ali Published in Nature (London) (28.01.2016)“...Wearable sensor technologies are essential to the realization of personalized medicine through continuously monitoring an individual's state of health...”